> top > docs > PMC:7205724 > spans > 18927-19106 > annotations

PMC:7205724 / 18927-19106 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
652 106-114 Species denotes patients Tax:9606
656 48-66 Chemical denotes methylprednisolone MESH:D008775

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T143 79-93 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T165 48-66 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T18 79-93 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulin http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T106 48-66 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T151 0-179 Sentence denotes After switching to the double dose of 1600 mg/d methylprednisolone plus 20 g/d immunoglobulin, all of the patients improved in the clinical, laboratory, and paraclinical outcomes.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
656 48-66 Chemical denotes methylprednisolone MESH:D008775
652 106-114 Species denotes patients Tax:9606

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T32422 0-5 IN denotes After
T38661 6-15 VBG denotes switching
T47400 16-18 TO denotes to
T27854 19-22 DT denotes the
T88178 23-29 JJ denotes double
T22917 30-34 NN denotes dose
T27562 35-37 IN denotes of
T69861 38-47 NN denotes 1600 mg/d
T26688 48-66 NN denotes methylprednisolone
T91618 67-71 CC denotes plus
T63033 72-78 NN denotes 20 g/d
T82872 79-93 NN denotes immunoglobulin
T48110 93-94 -COMMA- denotes ,
T64285 95-98 DT denotes all
T67888 99-101 IN denotes of
T16788 102-105 DT denotes the
T67776 106-114 NNS denotes patients
T6163 115-123 VBN denotes improved
T27596 124-126 IN denotes in
T10929 127-130 DT denotes the
T87507 131-139 JJ denotes clinical
T10805 139-140 -COMMA- denotes ,
T49266 141-151 NN denotes laboratory
T95692 151-152 -COMMA- denotes ,
T51590 153-156 CC denotes and
T63732 157-169 JJ denotes paraclinical
T58895 170-178 NNS denotes outcomes
R26413 T6163 T32422 arg1Of improved,After
R62745 T38661 T32422 arg2Of switching,After
R35046 T64285 T38661 arg1Of all,switching
R97543 T38661 T47400 arg1Of switching,to
R45642 T22917 T47400 arg2Of dose,to
R79576 T22917 T27854 arg1Of dose,the
R56085 T22917 T88178 arg1Of dose,double
R64025 T22917 T27562 arg1Of dose,of
R36622 T91618 T27562 arg2Of plus,of
R47040 T26688 T69861 arg1Of methylprednisolone,1600 mg/d
R96957 T26688 T91618 arg1Of methylprednisolone,plus
R59825 T82872 T91618 arg2Of immunoglobulin,plus
R2563 T82872 T63033 arg1Of immunoglobulin,20 g/d
R17542 T6163 T48110 arg1Of improved,","
R33163 T64285 T67888 arg1Of all,of
R47106 T67776 T67888 arg2Of patients,of
R68832 T67776 T16788 arg1Of patients,the
R41521 T64285 T6163 arg1Of all,improved
R92060 T6163 T27596 arg1Of improved,in
R79224 T58895 T27596 arg2Of outcomes,in
R14909 T58895 T10929 arg1Of outcomes,the
R43963 T58895 T87507 arg1Of outcomes,clinical
R46705 T87507 T10805 arg1Of clinical,","
R31644 T49266 T10805 arg2Of laboratory,","
R53992 T58895 T49266 arg1Of outcomes,laboratory
R52803 T51590 T95692 arg1Of and,","
R16749 T10805 T51590 arg1Of ",",and
R63324 T63732 T51590 arg2Of paraclinical,and
R41915 T58895 T63732 arg1Of outcomes,paraclinical

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T143 79-93 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T151 0-179 Sentence denotes After switching to the double dose of 1600 mg/d methylprednisolone plus 20 g/d immunoglobulin, all of the patients improved in the clinical, laboratory, and paraclinical outcomes.